Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

92 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Feasibility and Outcomes of a Third Allogeneic Hematopoietic Stem Cell Transplantation: A Retrospective Analysis from the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation.
Rank A, Peczynski C, Labopin M, Stelljes M, Simand C, Helbig G, Finke J, Santarone S, Tischer J, Lange A, Mistrik M, Houhou M, Schmid C, Nagler A, Mohty M. Rank A, et al. Transplant Cell Ther. 2021 May;27(5):408.e1-408.e6. doi: 10.1016/j.jtct.2021.01.025. Epub 2021 Feb 6. Transplant Cell Ther. 2021. PMID: 33965180 Free article.
In-vivo generation of leukaemia-derived dendritic cells.
Kolb HJ, Rank A, Chen X, Woiciechowsky A, Roskrow M, Schmid C, Tischer J, Ledderose G. Kolb HJ, et al. Among authors: rank a. Best Pract Res Clin Haematol. 2004 Sep;17(3):439-51. doi: 10.1016/j.beha.2004.06.004. Best Pract Res Clin Haematol. 2004. PMID: 15498715 Review.
Treatment, risk factors, and outcome of adults with relapsed AML after reduced intensity conditioning for allogeneic stem cell transplantation.
Schmid C, Labopin M, Nagler A, Niederwieser D, Castagna L, Tabrizi R, Stadler M, Kuball J, Cornelissen J, Vorlicek J, Socié G, Falda M, Vindeløv L, Ljungman P, Jackson G, Kröger N, Rank A, Polge E, Rocha V, Mohty M; Acute Leukaemia Working Party of the European Group for Blood and Marrow Transplantation (EBMT). Schmid C, et al. Among authors: rank a. Blood. 2012 Feb 9;119(6):1599-606. doi: 10.1182/blood-2011-08-375840. Epub 2011 Dec 13. Blood. 2012. PMID: 22167752 Free article.
Comparable outcome after haploidentical and HLA-matched allogeneic stem cell transplantation for high-risk acute myeloid leukemia following sequential conditioning-a matched pair analysis.
Doppelhammer M, Fraccaroli A, Prevalsek D, Bücklein V, Häbe S, Schulz C, Hubmann M, Hausmann A, Claus R, Rank A, Schmid C, Tischer J. Doppelhammer M, et al. Among authors: rank a. Ann Hematol. 2019 Mar;98(3):753-762. doi: 10.1007/s00277-019-03593-2. Epub 2019 Jan 8. Ann Hematol. 2019. PMID: 30617644
A multicenter prospective, randomized, placebo-controlled phase II/III trial for preemptive acute graft-versus-host disease therapy.
Weissinger EM, Metzger J, Schleuning M, Schmid C, Messinger D, Beutel G, Wagner-Drouet EM, Schetelig J, Baurmann H, Rank A, Stolzl F, Schäfer-Eckart K, Westphal K, Bethge W, von Harsdorf S, Bunjes DW, Heidenreich D, Klein S, Holler E, Kreipe HH, Jonigk D, Türüchanow I, Raad J, Papkalla A, von der Leyen H, Hambach L, Hamwi I, Ehrlich S, Krauter J, Stadler M, Ganser A. Weissinger EM, et al. Among authors: rank a. Leukemia. 2021 Jun;35(6):1763-1772. doi: 10.1038/s41375-020-01059-3. Epub 2020 Oct 20. Leukemia. 2021. PMID: 33082512 Free PMC article. Clinical Trial.
92 results